Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques (Q43586560)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2001

Language	Label	Description	Also known as
English	Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques	scientific article published in April 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Eaton JD

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Perry MJ

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Todryk SM

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Mazucco RA

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Kirby RS

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Griffiths JR

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Dalgleish AG

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

557-567

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

In vivo 31P MRS of experimental tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

In vivo 31P MRS evaluation of ganciclovir toxicity in C6 gliomas stably expressing the herpes simplex thymidine kinase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

Demonstration of a rational strategy for human prostate cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

31P NMR spectroscopic and near infrared spectrophotometric studies of effects of anesthetics on in vivo RIF-1 tumors. Relationship to tumor radiosensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

Studies of human tumors by MRS: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

Phospholipid metabolites as indicators of cancer cell function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interkukin-2 in peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

21 January 2018

Cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

7 January 2021

based on heuristic

inferred from DOI database lookup

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy of advanced prostate cancer: a phase I/II trial using Mycobacterium vaccae (SRL172)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of HLA class I expression in prostate cancer: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

7 January 2021

based on heuristic

inferred from DOI database lookup

31P-NMR investigation of solid tumours in the living rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

7 January 2021

based on heuristic

inferred from DOI database lookup

31P-NMR studies of a human tumour in situ

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycobacterium vaccae (SRL172): a potential immunological adjuvant evaluated in rat prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic whole-tumour cell vaccination in the rat model of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

7 January 2021

based on heuristic

inferred from DOI database lookup

Accurate quantification ofin vivo31P NMR signals using the variable projection method and prior knowledge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301432

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301432

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43586560&oldid=2206143809"